WallStreetZenWallStreetZen

NASDAQ: MAZE
Maze Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Maze Therapeutics earnings were N/A for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest MAZE earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$32.8M, up 568.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MAZE reported annual earnings of $3.4M, with -103.4% growth.

MAZE earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

MAZE Return on Equity

Insufficient data to display

MAZE undefined

Insufficient data to display

Be the first to know when MAZE announces earnings.

MAZE undefined

Current Company
0%
Current Industry
5.8%

MAZE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MAZEN/AN/AN/AN/A
NUVB-$605.02M-$606.38MN/A-$2.20
DNTH-$100.29M-$100.73MN/A-$2.89
SANA-$182.80M-$208.67MN/A-$0.88
BCAXN/AN/AN/AN/A
View Top Biotech Stocks

Maze Therapeutics Earnings Reports & History FAQ

What were Maze Therapeutics's earnings last quarter?

Maze Therapeutics (NASDAQ: MAZE) reported Q1 2025 earnings per share (EPS) of -$1.15, up 91.73% year over year. Total MAZE earnings for the quarter were -$32.79 million. In the same quarter last year, Maze Therapeutics's earnings per share (EPS) was -$13.91.

If you're new to stock investing, here's how to buy Maze Therapeutics stock.

Is Maze Therapeutics profitable or losing money?

As of the last Maze Therapeutics earnings report, Maze Therapeutics is currently losing money. Maze Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was N/A, a N/A decrease year over year.

What was MAZE's earnings growth in the past year?

As of Maze Therapeutics's earnings date in Q2 2025, Maze Therapeutics's earnings has grown year over year. MAZE earnings in the past year totalled N/A.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.